Genmab A-S (GMAB) had the highest return between May 1, 2012 and April 30, 2013 by a large-cap US stock, returning 297.9%.
| ASSET | DATE | % RETURN |
|---|---|---|
Genmab A-S (GMAB) | 5/1/2012 - 4/30/2013 | 297.86% |
Insmed (INSM) | 5/1/2012 - 4/30/2013 | 216.96% |
Netflix (NFLX) | 5/1/2012 - 4/30/2013 | 169.11% |
Ionis Pharmaceuticals (IONS) | 5/1/2012 - 4/30/2013 | 164.97% |
First Solar (FSLR) | 5/1/2012 - 4/30/2013 | 142.88% |
Madrigal Pharmaceuticals (MDGL) | 5/1/2012 - 4/30/2013 | 135.63% |
Apollo Global Management LLC Class A (APO) | 5/1/2012 - 4/30/2013 | 135.22% |
Constellation Brands Inc Class A (STZ) | 5/1/2012 - 4/30/2013 | 128.58% |
Nomura Holdings Inc ADR (NMR) | 5/1/2012 - 4/30/2013 | 119.89% |
Tenet Healthcare (THC) | 5/1/2012 - 4/30/2013 | 117.24% |
Saia (SAIA) | 5/1/2012 - 4/30/2013 | 117.2% |
PulteGroup (PHM) | 5/1/2012 - 4/30/2013 | 112.45% |
Alnylam Pharmaceuticals (ALNY) | 5/1/2012 - 4/30/2013 | 111.2% |
Vertex Pharmaceuticals (VRTX) | 5/1/2012 - 4/30/2013 | 100.05% |
Generac (GNRC) | 5/1/2012 - 4/30/2013 | 98.12% |
Terawulf (WULF) | 5/1/2012 - 4/30/2013 | 97.73% |
Gilead Sciences (GILD) | 5/1/2012 - 4/30/2013 | 94.96% |
Corpay (CPAY) | 5/1/2012 - 4/30/2013 | 93.65% |
Axon Enterprise (AXON) | 5/1/2012 - 4/30/2013 | 91.11% |
Biomarin Pharmaceutical (BMRN) | 5/1/2012 - 4/30/2013 | 88.83% |
Marathon Petroleum (MPC) | 5/1/2012 - 4/30/2013 | 87.93% |
Phillips 66 (PSX) | 5/1/2012 - 4/30/2013 | 83.53% |
Orix Corp Ads (IX) | 5/1/2012 - 4/30/2013 | 74.92% |
HF Sinclair (DINO) | 5/1/2012 - 4/30/2013 | 73.53% |
Smurfit WestRock (SW) | 5/1/2012 - 4/30/2013 | 72.52% |
Large-cap stocks are treated as having a market cap of $10B+.